ImaRx Therapeutics Report issue

For profit Phase 2
Founded: Hollywood FL United States (1999)
Status: Acquired by Cerevast Therapeutics, Inc. (2013)

Organization Overview

First Clinical Trial
2005
NCT00507806
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

maralixibat (LIVMARLI) (1 trial)

perflutren protein-type a microspheres (Optison) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 2)

Ischemia (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2